| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |